Compare PCRX & FCBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PCRX | FCBC |
|---|---|---|
| Founded | 2006 | 1874 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 888.3M |
| IPO Year | 2010 | 1996 |
| Metric | PCRX | FCBC |
|---|---|---|
| Price | $36.40 | $47.79 |
| Analyst Decision | Hold | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $33.57 | N/A |
| AVG Volume (30 Days) | ★ 2.3M | 103.6K |
| Earning Date | 11-13-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 4.94% |
| EPS Growth | ★ 107.44 | N/A |
| EPS | 0.19 | ★ 1.82 |
| Revenue | ★ $541,533,000.00 | N/A |
| Revenue This Year | $3.84 | $13.96 |
| Revenue Next Year | $4.73 | N/A |
| P/E Ratio | $191.58 | ★ $25.68 |
| Revenue Growth | ★ 26.04 | N/A |
| 52 Week Low | $18.80 | $31.21 |
| 52 Week High | $36.67 | $50.17 |
| Indicator | PCRX | FCBC |
|---|---|---|
| Relative Strength Index (RSI) | 83.12 | 49.73 |
| Support Level | $21.97 | $46.31 |
| Resistance Level | $36.45 | $49.64 |
| Average True Range (ATR) | 0.09 | 1.41 |
| MACD | -0.28 | -0.17 |
| Stochastic Oscillator | 25.35 | 45.34 |
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
First Community Bankshares Inc is a financial holding company that provides commercial banking products and services. The company is engaged in providing demand deposit accounts, savings, and money market accounts, certificates of deposits; commercial, consumer, and real estate mortgage loans, and lines of credit; various credit card, debit card, and automated teller machine card services; corporate and personal trust services; investment management services and life, health, and property and casualty insurance products. The company's revenue is mainly derived from interest, fees, and commissions.